Loading...
Significance of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Breast Cancer
Preclinical and clinical trials suggest that tyrosine kinase inhibitors (TKI) could supplement current therapies in metastatic breast cancer (MBC). HER-2 inhibition is still a main focus. Numerous agents targeting the epidermal growth factor receptors EGFR and HER-2 are currently tested after previo...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger GmbH
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2942000/ https://ncbi.nlm.nih.gov/pubmed/20877672 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000261705 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|